Diabetes Care, Vol 10, Issue 2 164-169, Copyright © 1987 by American Diabetes Association

ARTICLES

Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients

T Agner, P Damm and C Binder

To elucidate beta-cell function, insulin requirement, and remission period in insulin-dependent diabetes mellitus (IDDM), a study was undertaken comprising 268 patients consecutively admitted to Steno Memorial Hospital with newly diagnosed IDDM. The patients were characterized by sex, age, and seasonal variation at onset of diabetes mellitus. During the first 36 mo of the disease, an evaluation was performed for basal C-peptide, HbA1c, and insulin dose per kilogram. Total remission was interpreted as complete discontinuation of insulin therapy for at least 1 wk while still metabolically well controlled, and partial remission was interpreted as an insulin need that was less than or equal to 50% of the insulin dose at discharge from the hospital. During the first 18 mo of the disease, 12.3% of the patients entered total remission (median 6 mo), and 18.3% of the patients entered partial remission (median 6 mo). Patients entering remission had significantly higher basal C-peptide levels than those who did not. Sex, age, and initial HbA1c levels did not influence the frequency of remission.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Karges, I. Durinovic-Bello, E. Heinze, B. O. Boehm, K.-M. Debatin, and W. Karges Complete Long-Term Recovery of {beta}-Cell Function in Autoimmune Type 1 Diabetes After Insulin Treatment Diabetes Care, May 1, 2004; 27(5): 1207 - 1208. [Full Text] [PDF]

				K. Skak, C. F. Gotfredsen, D. Lundsgaard, J. B. Hansen, J. Sturis, and H. Markholst Improved {beta}-Cell Survival and Reduced Insulitis in a Type 1 Diabetic Rat Model After Treatment With a {beta}-Cell-Selective KATP Channel Opener Diabetes, April 1, 2004; 53(4): 1089 - 1095. [Abstract] [Full Text] [PDF]

				J. Ruxer, M. Mozdzan, L. Czupryniak, and J. Loba Long-Term Discontinuation of Insulin Treatment in a Type 1 Diabetic Patient: A case for late autoimmune diabetes of the adult? Diabetes Care, April 1, 2003; 26(4): 1314 - 1315. [Full Text] [PDF]

				C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al. Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4619 - 4623. [Abstract] [Full Text]

				B J. Muhammad, P. G F Swift, N. T Raymond, and J. L Botha Partial remission phase of diabetes in children younger than age 10 years Arch. Dis. Child., April 1, 1999; 80(4): 367 - 369. [Abstract] [Full Text]